Cannabidivarin
http://dbpedia.org/resource/Cannabidivarin an entity of type: Thing
La cannabidivarine (CBDV) est un cannabinoïde non psychoactif trouvé dans le cannabis. Elle est un homologue du cannabidiol (CBD), avec la chaîne latérale raccourcie par deux ponts méthylène (unités CH2). Les plantes à des niveaux relativement élevés de CBDV ont été signalées dans les populations sauvages de Cannabis indica (= C. sativa ssp. Indica var. kafiristanica) au nord-ouest de l'Inde, et de haschich en provenance du Népal. Tout comme le CBD, il a sept isomères de double liaison et trente stéréoisomères. Il n'est pas prévu par la convention sur les substances psychotropes.
rdf:langString
La cannabidivarina (CBDV) è un cannabinoide non psicoattivo trovato nella pianta di Cannabis. Si tratta di un omologo del cannabidiolo (CBD). Analogo al CBD, dispone di 7 isomeri a doppio legame e 30 stereoisomeri. Le piante con livelli relativamente alti di CBDV sono stati scoperti in colture selvatiche di Cannabis indica nel nord-ovest dell'India, e nell'hashish nepalese.
rdf:langString
Kannabidiwarin (CBDV) – organiczny związek chemiczny z grupy kannabinoidów występujący w konopiach. Nie wykazuje działania psychoaktywnego. CBDV jest prekursorem do biosyntezy psychoaktywnego kannabinoidu THCV.
rdf:langString
Cannabidivarin (CBDV, GWP42006) is a non-psychoactive cannabinoid found in Cannabis. It is a homolog (chemistry) of cannabidiol (CBD), with the side-chain shortened by two methylene bridges (CH2 units). Although cannabidivarin (CBDV) is usually a minor constituent of the cannabinoid profile, enhanced levels of CBDV have been reported in feral populations of C. indica ( = C. sativa ssp. indica var. kafiristanica) from northwest India, and in hashish from Nepal. CBDV has anticonvulsant effects. It was identified for the first time in 1969 by Vollner et al.
rdf:langString
Canabidivarina (CBDV, GWP42006) é um canabinoide não-psicoativo encontrado na Cannabis. É um homólogo do canabidiol (CBD), com a cadeia lateral substituída por duas pontes de metileno (CH2). Embora a canabidivarina (CBDV) seja considerada uma constituinte menor dos canabinoides presentes na Cannabis, níveis elevados de CBDV foram encontrados em cepas de C. indica (C. sativa ssp. indica var. kafiristanica) do noroeste da Índia e em amostras de haxixe do Nepal.
rdf:langString
rdf:langString
Cannabidivarin
rdf:langString
Cannabidivarina
rdf:langString
Cannabidivarine
rdf:langString
Kannabidiwarin
rdf:langString
Canabidivarina
xsd:integer
1232351
xsd:integer
1108936019
rdf:langString
none
xsd:integer
19
xsd:integer
24274
xsd:integer
2387742
xsd:integer
21106275
rdf:langString
DB14050
xsd:integer
26
rdf:langString
Cannabidivarin molecule ball.png
xsd:integer
2
<nicaraguanCórdoba>
20217.0
xsd:integer
2
xsd:integer
11601669
rdf:langString
C=C[C@H]2CCC=C/[C@@H]2c1ccccc1O
xsd:integer
1
rdf:langString
REOZWEGFPHTFEI-CVEARBPZSA-N
rdf:langString
I198VBV98I
rdf:langString
changed
xsd:integer
460016211
rdf:langString
changed
rdf:langString
Cannabidivarin (CBDV, GWP42006) is a non-psychoactive cannabinoid found in Cannabis. It is a homolog (chemistry) of cannabidiol (CBD), with the side-chain shortened by two methylene bridges (CH2 units). Although cannabidivarin (CBDV) is usually a minor constituent of the cannabinoid profile, enhanced levels of CBDV have been reported in feral populations of C. indica ( = C. sativa ssp. indica var. kafiristanica) from northwest India, and in hashish from Nepal. CBDV has anticonvulsant effects. It was identified for the first time in 1969 by Vollner et al. Similarly to CBD, it has seven double bond isomers and 30 stereoisomers (see: Cannabidiol#Isomerism). It is not scheduled by Convention on Psychotropic Substances. It is being actively developed by GW Pharmaceuticals (as GWP42006) because of a demonstrated neurochemical pathway for previously observed anti-epileptic and anti-convulsive action. GW has begun a phase 2 trial for adult epilepsy, and is to begin trials of this CBDV product in children in 2016 in Australia.
rdf:langString
La cannabidivarine (CBDV) est un cannabinoïde non psychoactif trouvé dans le cannabis. Elle est un homologue du cannabidiol (CBD), avec la chaîne latérale raccourcie par deux ponts méthylène (unités CH2). Les plantes à des niveaux relativement élevés de CBDV ont été signalées dans les populations sauvages de Cannabis indica (= C. sativa ssp. Indica var. kafiristanica) au nord-ouest de l'Inde, et de haschich en provenance du Népal. Tout comme le CBD, il a sept isomères de double liaison et trente stéréoisomères. Il n'est pas prévu par la convention sur les substances psychotropes.
rdf:langString
La cannabidivarina (CBDV) è un cannabinoide non psicoattivo trovato nella pianta di Cannabis. Si tratta di un omologo del cannabidiolo (CBD). Analogo al CBD, dispone di 7 isomeri a doppio legame e 30 stereoisomeri. Le piante con livelli relativamente alti di CBDV sono stati scoperti in colture selvatiche di Cannabis indica nel nord-ovest dell'India, e nell'hashish nepalese.
rdf:langString
Kannabidiwarin (CBDV) – organiczny związek chemiczny z grupy kannabinoidów występujący w konopiach. Nie wykazuje działania psychoaktywnego. CBDV jest prekursorem do biosyntezy psychoaktywnego kannabinoidu THCV.
rdf:langString
Canabidivarina (CBDV, GWP42006) é um canabinoide não-psicoativo encontrado na Cannabis. É um homólogo do canabidiol (CBD), com a cadeia lateral substituída por duas pontes de metileno (CH2). Embora a canabidivarina (CBDV) seja considerada uma constituinte menor dos canabinoides presentes na Cannabis, níveis elevados de CBDV foram encontrados em cepas de C. indica (C. sativa ssp. indica var. kafiristanica) do noroeste da Índia e em amostras de haxixe do Nepal. A CBDV é objeto de pesquisa científica por potenciais efeitos anticonvulsivantes e analgésicos. Foi identificada pela primeira vez em 1969 por Vollner et al. Da mesma forma que o CBD, possui sete isômeros de ligações duplas e 30 estereoisômeros. A canabividarina está sendo desenvolvida ativamente pela farmacêutica australiana GW Pharmaceuticals (sob o codinome GWP42006), principalmente por conta de uma via neuroquímica na qual atua como antiepiléptico e anticonvulsivante, propriedades já observadas anteriormente. A GW iniciou um estudo de fase 2 para epilepsia em adultos, e também planeja realizar testes em crianças na Austrália.
xsd:nonNegativeInteger
6821
xsd:string
24274-48-4
xsd:string
2387742
xsd:string
DB14050
xsd:string
I198VBV98I
xsd:string
C20217
xsd:string
11601669